- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/12 - Antidiarrhoeals
Patent holdings for IPC class A61P 1/12
Total number of patents in this class: 1027
10-year publication summary
|
26
|
32
|
57
|
61
|
60
|
69
|
78
|
72
|
53
|
46
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Finch Therapeutics Holdings, LLC | 74 |
22 |
| Société des Produits Nestlé S.A. | 9312 |
21 |
| N.V. Nutricia | 1064 |
20 |
| Takeda Pharmaceutical Company Limited | 2705 |
18 |
| Napo Pharmaceuticals, Inc. | 43 |
14 |
| University of Florida Research Foundation, Inc. | 4048 |
13 |
| Albireo AB | 170 |
13 |
| Nestec S.A. | 2656 |
11 |
| DSM IP Assets B.V. | 5581 |
9 |
| Array BioPharma Inc. | 497 |
9 |
| The Regents of the University of California | 20059 |
7 |
| Ajinomoto Co., Inc. | 2291 |
7 |
| Cedars-Sinai Medical Center | 1165 |
7 |
| Novartis AG | 10730 |
6 |
| Abbott Laboratories | 2400 |
6 |
| Compagnie Gervais Danone | 885 |
6 |
| Meiji Co., Ltd. | 728 |
6 |
| Thetis Pharmaceuticals LLC | 23 |
6 |
| Glycom A/S | 251 |
6 |
| Janssen Pharmaceutica N.V. | 3369 |
5 |
| Other owners | 815 |